Prognostic Implications of MALAT1 and BACH1 Expression and Their Correlation with CTCs and Mo-MDSCs in Triple Negative Breast Cancer and Surgical Management Options

<div>Flow cytometric detection of circulating tumor cells (CTCs). (a) CD45 and side scatter histogram was used to select the CD45 negative cells (R1). (b) The expressions of cytokeratin in CD45 negative. (c) CTCs were defined as EPCAM + cytokeratin + CD45-ve.</div>

International Journal of Breast Cancer

fig3

Figure 3

Figure 3: Prognostic Implications of MALAT1 and BACH1 Expression and Their Correlation with CTCs and Mo-MDSCs in Triple Negative Breast Cancer and Surgical Management Options 

Figure 3 | Prognostic Implications of MALAT1 and BACH1 Expression and Their Correlation with CTCs and Mo-MDSCs in Triple Negative Breast Cancer and Surgical Management Options 